Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapynews2026-04-24T14:00:16+00:00April 24th, 2026|Endpoints News|
Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejectionnews2026-04-24T11:30:21+00:00April 24th, 2026|Endpoints News|
Pfizer’s strategy chief Andrew Baum steps down; Helus Pharma swaps out CEO after two monthsnews2026-04-24T11:00:13+00:00April 24th, 2026|Endpoints News|
Daiichi Sankyo postpones annual results, stock dipsnews2026-04-24T09:32:42+00:00April 24th, 2026|Endpoints News|
FDA approves Regeneron’s hearing loss gene therapy Otarmeninews2026-04-23T18:53:40+00:00April 23rd, 2026|Endpoints News|
Substance use disorder biotech Tempero to close after earlier ‘serious’ safety eventnews2026-04-23T18:13:36+00:00April 23rd, 2026|Endpoints News|
Post-Hoc Live: MAHA, the new Trump CDC pick and RFK’s vaccine agendanews2026-04-23T17:56:45+00:00April 23rd, 2026|Endpoints News|
Novartis’ radioligand therapy Lutathera could soon face generic competitionnews2026-04-23T17:49:23+00:00April 23rd, 2026|Endpoints News|
The Godmother of Silicon Valley is helping launch an AI healthcare residency programnews2026-04-23T14:54:27+00:00April 23rd, 2026|Endpoints News|
